Paolo A Cortesi Selected Research

Paolo A Cortesi Research Topics

3	Liver Diseases (Liver Disease) 11/2020 - 10/2018
3	Fibrosis (Cirrhosis) 11/2020 - 10/2018
2	Acute-On-Chronic Liver Failure 01/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 01/2021
2	Infections 01/2021 - 10/2018
2	Hepatocellular Carcinoma (Hepatoma) 12/2018 - 10/2018
2	Hemophilia A (Haemophilia) 12/2017 - 12/2017
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2021
1	Peripheral Arterial Disease 05/2021
1	Hypercholesterolemia 01/2021
1	COVID-19 01/2021
1	Non-alcoholic Fatty Liver Disease 11/2020
1	Chronic Hepatitis (Chronic Active Hepatitis) 11/2020
1	Multiple Sclerosis 04/2020
1	Hepatitis B 10/2018
1	Failed Back Surgery Syndrome 01/2018
1	Heart Failure 11/2017
1	Hemorrhage 09/2017
1	Chronic Hepatitis C 01/2017
1	Psoriatic Arthritis 01/2016
1	Necrosis 01/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2015
1	Eczema 03/2014
1	Inflammation (Inflammations) 07/2012

3	Antiviral Agents (Antivirals)IBA 12/2018 - 01/2017
2	clonidine-displacing substance (ClDS)IBA 11/2020 - 01/2020
2	Factor VIII (Coagulation Factor VIII)IBA 12/2017 - 09/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2021
1	Factor Xa (Coagulation Factor Xa)IBA 05/2021
1	RivaroxabanIBA 05/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	LDL CholesterolIBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	CannabinoidsIBA 04/2020
1	anti-inhibitor coagulant complexIBA 12/2017
1	Prothrombin (Factor II)IBA 12/2017
1	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2017
1	Tumor Necrosis Factor InhibitorsIBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2014
1	Methotrexate (Mexate)FDA LinkGeneric 07/2012

5	Liver Transplantation 01/2022 - 10/2018
5	Therapeutics 01/2021 - 07/2012
1	Salvage Therapy 01/2021
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2021
1	Spinal Cord Stimulation 01/2018
1	Biological Therapy 02/2015